The IPC Biosimilars Conference 2026 is a national-level scientific event organized by the Indian Pharmacopoeia Commission (IPC) in technical collaboration with the Indian Drug Manufacturers’ Association (IDMA). The conference focuses on the quality, safety, regulatory landscape, pharmacovigilance, and future of biosimilars in India.

Contents

1. Who is organizing the IPC Biosimilars Conference 2026?2. When will the conference be held?3. Where is the conference venue?4. What is the registration fee?5. Who can attend the conference?6. What are the major topics covered?7. What is the last date to register?8. Is this a recruitment notification?

If you are a B.Pharm, M.Pharm, PhD scholar, researcher, QA/QC professional, Regulatory Affairs executive, or biologics industry professional, this conference offers an excellent opportunity to learn from experts and stay updated with the latest developments in India’s rapidly growing biopharmaceutical sector.

Quick Summary

The IPC National Conference on Quality and Safety of Biosimilars 2026 will be held on 10–11 September 2026 in Bengaluru. Organized by the Indian Pharmacopoeia Commission (IPC), the conference will cover biosimilar development, regulatory affairs, pharmacovigilance, quality standards, and next-generation biotherapeutics. Registration closes on 18 August 2026.

AIIMS New Delhi Recruitment 2026: B.Pharm Apply

Overview

Particular	Details
Conference Name	National Conference on Quality and Safety of Biosimilars
Theme	Strengthening India’s Biopharma SHAKTI Vision
Organized By	Indian Pharmacopoeia Commission (IPC)
Technical Partner	Indian Drug Manufacturers’ Association (IDMA)
Conference Dates	10–11 September 2026
Time	9:00 AM – 5:00 PM
Venue	C-CAMP, Dasheri Auditorium, NCBS-TIFR Campus, Bengaluru
Registration Deadline	18 August 2026

About Indian Pharmacopoeia Commission (IPC)

The Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Health & Family Welfare, Government of India.

IPC is responsible for:

Publishing the Indian Pharmacopoeia
Updating drug quality standards
Publishing the National Formulary of India
Providing Indian Pharmacopoeia Reference Substances
Coordinating the Pharmacovigilance Programme of India (PvPI)
Coordinating the Materiovigilance Programme of India (MvPI)
Conducting skill development programmes

IPC plays a crucial role in ensuring the quality, safety, and efficacy of medicines and medical devices in India.

Why This Conference is Important

India is one of the world’s leading manufacturers of biosimilars.

With increasing demand for affordable biological medicines, maintaining high standards of quality, regulatory compliance, manufacturing excellence, and pharmacovigilance has become essential.

This conference supports India’s Biopharma SHAKTI Vision by bringing together regulators, scientists, manufacturers, researchers, and industry experts on one platform.

Conference Topics

The conference will cover the following key areas:

Pharmacopoeial Standards for Biosimilars
Development and Characterization of Biosimilars
Regulatory Landscape for Biotherapeutics
Next Generation Biotherapeutics
Pharmacovigilance of Biosimilars
Quality Assurance in Biosimilar Manufacturing
Emerging Regulatory Challenges
Future Trends in Biosimilar Development

Expert Speakers

Participants will interact with experts from:

Indian Pharmacopoeia Commission (IPC)
Drug Regulatory Authorities
DBT-BIRAC
Indian Drug Manufacturers’ Association (IDMA)
Centre for Cellular and Molecular Platforms (C-CAMP)
Biosimilar Industry
Leading Academic Institutions
Pharmacovigilance Experts

Eligibility

The conference is open to:

B.Pharm Students
M.Pharm Students
PhD Scholars
Scientists
Researchers
Manufacturing Professionals
Process Development Teams
QA Professionals
QC Professionals
Regulatory Affairs Professionals
Drug Regulatory Officials
Pharmacovigilance Professionals
Drug Safety Professionals
MSMEs working in Biologics and Biosimilars

Registration Fee

Category	Fee
Academia & Research Scholars	₹2,500 + 18% GST
Industry Professionals	₹5,000 + 18% GST

Important Dates

Event	Date
Registration Deadline	18 August 2026
Conference Dates	10–11 September 2026

Venue

Centre for Cellular and Molecular Platforms (C-CAMP)
Dasheri Auditorium
NCBS-TIFR Campus
Bellary Road
GKVK Post
Bengaluru – 560065

How to Register

Interested participants should complete the registration process through the official Indian Pharmacopoeia Commission (IPC) registration portal before the registration deadline.

Note: The detailed registration link and payment instructions should be verified on the official conference notification.

Why Should Pharmacy Candidates Attend?

Attending this conference can help pharmacy students and professionals:

Learn directly from national regulatory experts.
Understand current biosimilar regulations.
Explore career opportunities in Biopharma.
Gain knowledge of pharmacovigilance practices.
Network with scientists and industry professionals.
Stay updated on emerging biologics technologies.
Enhance skills in Regulatory Affairs, QA, and QC.
Strengthen academic and professional profiles.

Benefits of Attending

Participants will gain:

Latest updates on biosimilar regulations
Knowledge of pharmacopoeial standards
Insights into next-generation biotherapeutics
Exposure to drug safety and pharmacovigilance
Networking opportunities with industry leaders
Practical understanding of biosimilar development

Vacancy Details

Not mentioned in the official notification.

Age Limit

Not mentioned in the official notification.

Salary

Not applicable. This is a scientific conference, not a recruitment notification.

Selection Process

Not applicable. Registration is based on participant enrollment.

Important Links

Particular	Status
Official Conference Notification	Refer to the official IPC notification
Registration Link	Available through the official IPC registration portal
Official Website	Indian Pharmacopoeia Commission (IPC)

Conclusion

The IPC National Conference on Quality and Safety of Biosimilars 2026 is a valuable learning platform for pharmacy students, researchers, scientists, regulatory professionals, and industry experts. With sessions covering biosimilar development, regulatory science, pharmacovigilance, and next-generation biotherapeutics, participants can gain practical insights while expanding their professional network.

Those interested should complete their registration before 18 August 2026 to secure their participation.

Frequently Asked Questions (FAQs)

1. Who is organizing the IPC Biosimilars Conference 2026?

The conference is organized by the Indian Pharmacopoeia Commission (IPC) in technical collaboration with the Indian Drug Manufacturers’ Association (IDMA).

2. When will the conference be held?

The conference will be held on 10–11 September 2026.

3. Where is the conference venue?

The venue is C-CAMP, Dasheri Auditorium, NCBS-TIFR Campus, Bengaluru.

4. What is the registration fee?

Academia & Research Scholars: ₹2,500 + GST
Industry Professionals: ₹5,000 + GST

5. Who can attend the conference?

B.Pharm, M.Pharm, PhD scholars, researchers, QA/QC professionals, Regulatory Affairs professionals, scientists, pharmacovigilance experts, and industry professionals.